SRXN1 is a novel protective factor against methylmercury-induced apoptosis in C17.2 mouse neural stem cells.

Authors: Yamashita, Naoya, Yokoyama, Yukie, Kumagai, Ayano, Fukushima, Ryoko, Yamagata, Ryota, Hwang, Gi‑Wook

Source: Toxicological Research; Mar2025, Vol. 41 Issue 2, p167-173, 7p

Comparative analyses of immune cells and alpha-smooth muscle actin-positive cells under the immunological microenvironment between with and without dense fibrosis in primary central nervous system lymphoma.

Authors: Takei, Jun, Maeda, Miku, Fukasawa, Nei, Kawashima, Masaharu, Miyake, Misayo, Tomoto, Kyoichi, Nawate, Shohei, Teshigawara, Akihiko, Suzuki, Tomoya, Yamamoto, Yohei, Nagashima, Hiroyasu, Mori, Ryosuke, Fukushima, Ryoko, Matsushima, Satoshi, Kino, Hiroyoshi, Muroi, Ai, Tsurubuchi, Takao, Sakamoto, Noriaki, Nishiwaki, Kaichi, Yano, Shingo

Source: Brain Tumor Pathology; Oct2024, Vol. 41 Issue 3/4, p97-108, 12p

Methylmercury exposure at dosage conditions that do not affect growth can impair memory in adolescent mice.

Authors: Yamagata, Ryota, Saito, Ai, Fukushima, Ryoko, Nakagawasai, Osamu, Yamashita, Naoya, Tan-No, Koichi, Hwang, Gi-Wook

Source: Toxicological Research; Jul2024, Vol. 40 Issue 3, p441-448, 8p

Clinical features of suicide attempts in adults with autism spectrum disorders

Authors: Kato, Koji, Mikami, Katsunaka, Akama, Fumiaki, Yamada, Keigo, Maehara, Mizuki, Kimoto, Keitaro, Kimoto, Kousuke, Sato, Reiko, Takahashi, Yuki, Fukushima, Ryoko, Ichimura, Atsushi, Matsumoto, Hideo

Source: In General Hospital Psychiatry January-February 2013 35(1):50-53

The Role of High-Dose Regimens Followed By Autologous Stem Cell Transplantation for Salvage Chemotherapy-Sensitive DLBCL Patients

Authors: Momoki, Mamiko, Katsube, Atsushi, Kawashima, Masaharu, Suzuki, Kazuhito, Fukushima, Ryoko, Gunji, Tadahiro, Ishii, Hiroto, Uryu, Hideki, Nishiwaki, Kaichi, Yano, Shingo

Source: In Blood 2 November 2023 142 Supplement 1:7063-7063

P-091: Thrombocytopenia with coagulation abnormality in multiple myeloma patients treated with proteasome inhibitor and/or immunomodulatory drugs

Authors: Suzuki, Kazuhito, Nishiwaki, Kaichi, Nagao, Riku, Katori, Mitsuji, Fukushima, Ryoko, Sakayori, Yo, Masuoka, Hidekazu, Yano, Shingo

Source: In Clinical Lymphoma, Myeloma and Leukemia August 2022 22 Supplement:S85-S86

Clinical significance of the lymphocyte-to-monocyte ratio in multiple myeloma patients with negative minimal residual disease: a single-center retrospective analysis.

Authors: Suzuki, Kazuhito, Nishiwaki, Kaichi, Nagao, Riku, Katori, Mitsuji, Fukushima, Ryoko, Hattori, Daiki, Masuoka, Hidekazu, Yano, Shingo

Source: International Journal of Hematology; Nov2021, Vol. 114 Issue 5, p599-607, 9p

Successful bridge therapy of gilteritinib to cord blood transplantation in relapsed acute myeloid leukemia after bone marrow transplantation

Authors: Kamitani, Iku, Saito, Takeshi, Yokoyama, Hiroki, Nakano, Aya, Ishii, Hiroto, Tanoue, Susumu, Hattori, Daiki, Oshima, Sayaka, Ishii, Shoko, Gunji, Tadahiro, Fukushima, Ryoko, Katsube, Atsushi, Shimada, Takaki, Nishiwaki, Kaichi, Dobashi, Nobuaki, Yano, Shingo

Source: In Journal of Infection and Chemotherapy April 2021 27(4):639-641

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

O2-11-5 - A Retrospective Analysis of Irinotecan for Heavily Pretreated Esophageal Squamous Cell Carcinoma

Authors: Fukushima, Ryoko, Iwasa, Satoru, Shoji, Hirokazu, Okita, Natsuko, Takashima, Atsuo, Honma, Yoshitaka, Kato, Ken, Hamaguchi, Tetsuya, Yamada, Yasuhide, Shimada, Yasuhiro

Source: In Annals of Oncology October 2014 25 Supplement 5:v64-v64